Data / Form D filings / COFACTOR GENOMICS, INC.
COFACTOR GENOMICS, INC.: Form D filings
COFACTOR GENOMICS, INC., a biotechnology company in San Francisco, CA, filed 3 Form D notices with the SEC between 2017 and 2023. The latest, on August 2, 2023, reports $1.2 million sold of a $2 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 300 Brannan St, Ste 410, San Francisco, CA, 94107
- Phone
- (415) 506-7633
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1710475
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 2, 2023 | New notice | $2,000,000 | $1,174,682 | $825,318 | 2 | Jul 20, 2023 | sec.gov |
| Dec 16, 2021 | New notice | $7,056,712 | $6,906,712 | $150,000 | 9 | Dec 8, 2021 | sec.gov |
| Jun 28, 2017 | New notice | $15,109,999 | $10,683,766 | $4,426,233 | 23 | Jun 14, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William Hagstrom | Director | |
| David Messina | Executive Officer | |
| John Kuelper | Executive Officer, Director | |
| Jarret Glasscock | Executive Officer, Director | |
| Mark Siegel | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 31, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what COFACTOR GENOMICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.